Integra LifeSciences Holdings Corp., based in Princeton, New Jersey, specializes in regenerative tissue technologies and neurological solutions, employing 3,722 people and operating through two segments: Codman Specialty Surgical and Tissue Technologies. The company offers a range of medical products, including neurosurgery instruments and complex wound surgery solutions, across multiple global manufacturing and research sites.
IART has been in the news recently: Integra LifeSciences will announce its second quarter 2024 financial results on July 29, 2024, with a conference call at 8:30 a.m. ET. The company plans to resume manufacturing PriMatrix® and SurgiMend® at a new facility in Braintree, Massachusetts by the first half of 2026.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
